Oragenics Stock (AMEX: OGEN) stock price, news, charts, stock research, profile.
Open | $1.470 |
Close | $1.840 |
Volume / Avg. | 440.842K / 93.866K |
Day Range | 1.402 - 1.890 |
52 Wk Range | 1.000 - 7.740 |
Market Cap | $8.110M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 71 |
Short Interest | 0.9% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Oragenics (AMEX: OGEN) through any online brokerage.
Other companies in Oragenics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), NuCana (NASDAQ:NCNA), Genprex (NASDAQ:GNPX) and Portage Biotech (NASDAQ:PRTG).
The latest price target for Oragenics (AMEX: OGEN) was reported by HC Wainwright & Co. on Thursday, April 16, 2020. The analyst firm set a price target for 0.00 expecting OGEN to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Oragenics (AMEX: OGEN) is $1.84 last updated May 10, 2024 at 8:00 PM EDT.
There are no upcoming dividends for Oragenics.
Oragenics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Oragenics.
Oragenics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.